[8-K] Cardinal Health, Inc. Reports Material Event
Cardinal Health, Inc. announced the sale of $1.0 billion of senior notes: $600,000,000 of 4.500% Notes due 2030 and $400,000,000 of 5.150% Notes due 2035, under an effective Form S-3ASR registration statement. The offering was made through an underwriting agreement dated August 13, 2025, with Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC serving as representatives of the underwriters. The disclosure references the registration statement number and notes that the cover page interactive data file is embedded in the Inline XBRL document. The Form 8-K is signed by Aaron E. Alt, Chief Financial Officer, and dated August 14, 2025.
Cardinal Health, Inc. ha annunciato la vendita di titoli senior per 1,0 miliardi di dollari: 600,000,000 di Note al 4.500% in scadenza 2030 e 400,000,000 di Note al 5.150% in scadenza 2035, ai sensi di una dichiarazione di registrazione Form S-3ASR efficace. L'offerta è stata effettuata tramite un accordo di sottoscrizione datato 13 agosto 2025, con Goldman Sachs & Co. LLC, BofA Securities, Inc. e Wells Fargo Securities, LLC in qualità di rappresentanti dei sottoscrittori. La documentazione fa riferimento al numero della dichiarazione di registrazione e indica che il file dei dati interattivi della copertina è incorporato nel documento Inline XBRL. Il Modulo 8-K è firmato da Aaron E. Alt, Chief Financial Officer, e datato 14 agosto 2025.
Cardinal Health, Inc. anunció la emisión de deuda senior por 1.0 mil millones de dólares: 600,000,000 de Notas al 4.500% con vencimiento en 2030 y 400,000,000 de Notas al 5.150% con vencimiento en 2035, bajo una declaración de registro Form S-3ASR efectiva. La oferta se realizó mediante un contrato de suscripción fechado el 13 de agosto de 2025, con Goldman Sachs & Co. LLC, BofA Securities, Inc. y Wells Fargo Securities, LLC como representantes de los suscriptores. La divulgación hace referencia al número de la declaración de registro y señala que el archivo de datos interactivos de la portada está incorporado en el documento Inline XBRL. El Formulario 8-K está firmado por Aaron E. Alt, Chief Financial Officer, y fechado el 14 de agosto de 2025.
Cardinal Health, Inc.는 10억 달러 규모의 시니어 노트를 발행했다고 발표했습니다: 2030년 만기 4.500% 노트 600,000,000달러 및 2035년 만기 5.150% 노트 400,000,000달러, 유효한 Form S-3ASR 등록서에 따라 이루어졌습니다. 본 공모는 2025년 8월 13일자 인수계약을 통해 진행되었으며, Goldman Sachs & Co. LLC, BofA Securities, Inc., Wells Fargo Securities, LLC가 인수단 대표로 참여했습니다. 공시에는 등록서 번호가 언급되어 있고 표지의 대화형 데이터 파일이 Inline XBRL 문서에 포함되어 있다고 명시되어 있습니다. Form 8-K는 최고재무책임자(Chief Financial Officer) Aaron E. Alt가 서명했으며 날짜는 2025년 8월 14일입니다.
Cardinal Health, Inc. a annoncé la cession de 1,0 milliard de dollars de titres senior : 600,000,000 de Notes à 4.500% arrivant à échéance en 2030 et 400,000,000 de Notes à 5.150% arrivant à échéance en 2035, dans le cadre d'une déclaration d'enregistrement Form S-3ASR effective. L'offre a été réalisée par un contrat de souscription daté du 13 août 2025, avec Goldman Sachs & Co. LLC, BofA Securities, Inc. et Wells Fargo Securities, LLC agissant en tant que représentants des souscripteurs. La communication renvoie au numéro de la déclaration d'enregistrement et indique que le fichier de données interactives de la page de couverture est intégré au document Inline XBRL. Le formulaire 8-K est signé par Aaron E. Alt, Chief Financial Officer, et daté du 14 août 2025.
Cardinal Health, Inc. gab den Verkauf von Senior Notes in Höhe von 1,0 Milliarden US-Dollar bekannt: 600,000,000 von 4.500% Notes fällig 2030 und 400,000,000 von 5.150% Notes fällig 2035, gemäß einer wirksamen Form S-3ASR-Registrierungserklärung. Das Angebot erfolgte durch ein Zeichnungsabkommen vom 13. August 2025, wobei Goldman Sachs & Co. LLC, BofA Securities, Inc. und Wells Fargo Securities, LLC als Vertreter der Zeichner fungierten. Die Offenlegung verweist auf die Registrierungsnummer und weist darauf hin, dass die interaktiven Titelseitendaten in das Inline-XBRL-Dokument eingebettet sind. Das Formular 8-K ist von Aaron E. Alt, Chief Financial Officer, unterzeichnet und auf den 14. August 2025 datiert.
- $1.0 billion of capital raised via notes provides material additional liquidity on the balance sheet
- Two-maturity structure (2030 and 2035) secures long-term fixed-rate financing and staggers maturities
- Underwritten by major banks (Goldman Sachs, BofA, Wells Fargo), indicating broad distribution and market access
- Filing does not disclose use of proceeds, preventing assessment of whether debt funds growth, refinancing, or operations
- No information provided on credit ratings or projected impact on leverage ratios
- Details on optional redemption, covenants, or final settlement net proceeds are not included
Insights
TL;DR: Cardinal Health issued $1.0 billion of fixed-rate notes across 2030 and 2035 maturities to raise long-term financing.
The company sold $600 million of 4.50% notes due 2030 and $400 million of 5.15% notes due 2035 under an effective S-3ASR registration. This transaction increases Cardinal Health's long-term debt by $1.0 billion and secures fixed-rate funding across two maturities, which can be used for general corporate purposes, refinancing, or liquidity needs (the filing does not specify the use of proceeds). The underwriting was led by major investment banks, indicating standard market distribution. The filing provides basic transactional facts but does not include pricing yields beyond coupon, use-of-proceeds details, covenant specifics, or ratings impact.
TL;DR: A two-tranche bond issuance totaling $1.0 billion at fixed coupons suggests active access to the capital markets.
The issuance splits into 2030 and 2035 maturities with coupons of 4.50% and 5.15%, respectively, reflecting term premium for the longer tranche. The underwriting agreement dated August 13, 2025 and placement under an effective Form S-3ASR are standard procedural disclosures. The document does not disclose final net proceeds, expected settlement date, credit ratings, or any optional redemption terms, limiting assessment of refinancing impact and cost of capital changes.
Cardinal Health, Inc. ha annunciato la vendita di titoli senior per 1,0 miliardi di dollari: 600,000,000 di Note al 4.500% in scadenza 2030 e 400,000,000 di Note al 5.150% in scadenza 2035, ai sensi di una dichiarazione di registrazione Form S-3ASR efficace. L'offerta è stata effettuata tramite un accordo di sottoscrizione datato 13 agosto 2025, con Goldman Sachs & Co. LLC, BofA Securities, Inc. e Wells Fargo Securities, LLC in qualità di rappresentanti dei sottoscrittori. La documentazione fa riferimento al numero della dichiarazione di registrazione e indica che il file dei dati interattivi della copertina è incorporato nel documento Inline XBRL. Il Modulo 8-K è firmato da Aaron E. Alt, Chief Financial Officer, e datato 14 agosto 2025.
Cardinal Health, Inc. anunció la emisión de deuda senior por 1.0 mil millones de dólares: 600,000,000 de Notas al 4.500% con vencimiento en 2030 y 400,000,000 de Notas al 5.150% con vencimiento en 2035, bajo una declaración de registro Form S-3ASR efectiva. La oferta se realizó mediante un contrato de suscripción fechado el 13 de agosto de 2025, con Goldman Sachs & Co. LLC, BofA Securities, Inc. y Wells Fargo Securities, LLC como representantes de los suscriptores. La divulgación hace referencia al número de la declaración de registro y señala que el archivo de datos interactivos de la portada está incorporado en el documento Inline XBRL. El Formulario 8-K está firmado por Aaron E. Alt, Chief Financial Officer, y fechado el 14 de agosto de 2025.
Cardinal Health, Inc.는 10억 달러 규모의 시니어 노트를 발행했다고 발표했습니다: 2030년 만기 4.500% 노트 600,000,000달러 및 2035년 만기 5.150% 노트 400,000,000달러, 유효한 Form S-3ASR 등록서에 따라 이루어졌습니다. 본 공모는 2025년 8월 13일자 인수계약을 통해 진행되었으며, Goldman Sachs & Co. LLC, BofA Securities, Inc., Wells Fargo Securities, LLC가 인수단 대표로 참여했습니다. 공시에는 등록서 번호가 언급되어 있고 표지의 대화형 데이터 파일이 Inline XBRL 문서에 포함되어 있다고 명시되어 있습니다. Form 8-K는 최고재무책임자(Chief Financial Officer) Aaron E. Alt가 서명했으며 날짜는 2025년 8월 14일입니다.
Cardinal Health, Inc. a annoncé la cession de 1,0 milliard de dollars de titres senior : 600,000,000 de Notes à 4.500% arrivant à échéance en 2030 et 400,000,000 de Notes à 5.150% arrivant à échéance en 2035, dans le cadre d'une déclaration d'enregistrement Form S-3ASR effective. L'offre a été réalisée par un contrat de souscription daté du 13 août 2025, avec Goldman Sachs & Co. LLC, BofA Securities, Inc. et Wells Fargo Securities, LLC agissant en tant que représentants des souscripteurs. La communication renvoie au numéro de la déclaration d'enregistrement et indique que le fichier de données interactives de la page de couverture est intégré au document Inline XBRL. Le formulaire 8-K est signé par Aaron E. Alt, Chief Financial Officer, et daté du 14 août 2025.
Cardinal Health, Inc. gab den Verkauf von Senior Notes in Höhe von 1,0 Milliarden US-Dollar bekannt: 600,000,000 von 4.500% Notes fällig 2030 und 400,000,000 von 5.150% Notes fällig 2035, gemäß einer wirksamen Form S-3ASR-Registrierungserklärung. Das Angebot erfolgte durch ein Zeichnungsabkommen vom 13. August 2025, wobei Goldman Sachs & Co. LLC, BofA Securities, Inc. und Wells Fargo Securities, LLC als Vertreter der Zeichner fungierten. Die Offenlegung verweist auf die Registrierungsnummer und weist darauf hin, dass die interaktiven Titelseitendaten in das Inline-XBRL-Dokument eingebettet sind. Das Formular 8-K ist von Aaron E. Alt, Chief Financial Officer, unterzeichnet und auf den 14. August 2025 datiert.
FAQ
What notes did Cardinal Health (CAH) issue in this filing?
How much total capital did CAH raise with these notes?
Who were the lead underwriters for Cardinal Health's offering?
Under what registration statement was the offering made?
When was the underwriting agreement dated and who signed the 8-K?
